SCHEMBL54924

SCHEMBL54924

CC(=O)CC(=O)Nc1cc(Cl)ccc1Cl

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.80
KMT2A Q03164 4/20 0.80
POLB P06746 3/20 0.80
ALDH1A1 P00352 3/20 0.68
GAA P10253 5/20 0.60
LMNA P02545 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
ALOX12 P18054 1/20 0.60
CYP2C19 P33261 1/20 0.60
EPHX1 P07099 1/20 0.58
HTT P42858 1/20 0.53
TDP1 Q9NUW8 1/20 0.51
PDK1 Q15118 1/20 0.51
PDK2 Q15119 1/20 0.51
PDK3 Q15120 1/20 0.51
PDK4 Q16654 1/20 0.51
USP2 O75604 1/20 0.51
HPGD P15428 1/20 0.51
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9180503 0.86 HPGD (0.68) MEN1KMT2APOLBALDH1A1GAA
SCHEMBL31590796 0.86 HPGD (0.68) MEN1KMT2APOLBALDH1A1GAA
SCHEMBL31570100 0.85 MEN1 (0.57) MEN1KMT2APOLBALDH1A1GAA
SCHEMBL9181550 0.85 POLB (0.69) MEN1KMT2APOLBALDH1A1GAA
SCHEMBL17680989 0.84 KMT2A (0.77) MEN1KMT2APOLBALDH1A1GAA
SCHEMBL2914539 0.83 ALDH1A1 (0.54) MEN1KMT2APOLBALDH1A1GAA
SCHEMBL2680891 0.82 MEN1 (0.79) MEN1KMT2APOLBALDH1A1GAA
SCHEMBL7530798 0.82 ALDH1A1 (0.57) MEN1KMT2APOLBALDH1A1CYP1A2
SCHEMBL7080579 0.82 MEN1 (0.75) MEN1KMT2APOLBALDH1A1
SCHEMBL2388970 0.82 EPHX1 (0.70) MEN1KMT2APOLBALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025100475-A1 COMPOSITION FOR IMAGE RECORDING AND METHOD FOR PRODUCING SAME キヤノン株式会社 2025-05-15 WO disclosed
US-8586696-B2 Zirconium compound, catalyst and its use for polyurethane manufacture DORF KETAL CHEMICALS (INDIA) PVT. LTD (IN) 2013-11-19 US disclosed
US-8129163-B2 Gene suitable for alcohol dehydrogenase, vector and transformant KANEKA CORPORATION (JP) 2012-03-06 US disclosed
US-20100035317-A1 NOVEL ALCOHOL DEHYDROGENASE, GENE FOR THE ALCOHOL DEHYDROGENASE, VECTOR, TRANSFORMANT, AND METHOD FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOL BY USING THEM KANEKA CORPORATION (JP) 2010-02-11 US disclosed
EP-2096165-A1 NOVEL ALCOHOL DEHYDROGENASE, GENE FOR THE ALCOHOL DEHYDROGENASE, VECTOR, TRANSFORMANT, AND METHOD FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOL BY USING THEM Kaneka Corporation (JP) 2009-09-02 EP disclosed
US-20080312402-A1 Novel Zirconium Compound, Catalyst and Its Use for Polyurethane Manufacture JOHNSON MATTHEY PLC (GB) 2008-12-18 US disclosed
EP-1899061-A1 NOVEL ZIRCONIUM COMPOUND, CATALYST AND ITS USE FOR POLYURETHANE MANUFACTURE Johnson Matthey Public Limited Company (GB) 2008-03-19 EP disclosed
WO-2007003966-A1 NOVEL ZIRCONIUM COMPOUND, CATALYST AND ITS USE FOR POLYURETHANE MANUFACTURE JOHNSON MATTHEY PLC (GB) 2007-01-11 WO disclosed
US-20060079593-A1 Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same SHOWA DENKO K.K. (JP) 2006-04-13 US disclosed
EP-0103968-B1 FORTIFIER FOR EPOXY RESINS, METHOD FOR THE PREPARATION THEREOF AND FORTIFIED EPOXY RESIN COMPOSITIONS CONTAINING SAME Canadian Patents and Development Limited Société Canadienne des Brevets et d'Exploitation Limitée (CA) 1987-07-22 EP disclosed
US-4474609-A Recrystallization-resistant monoazo pigment mixtures of high tinctorial strength, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1984-10-02 US disclosed
US-4469515-A Production of pigments CIBA-GEIGY CORPORATION (US) 1984-09-04 US disclosed
EP-0103968-A1 Fortifier for epoxy resins, method for the preparation thereof and fortified epoxy resin compositions containing same Canadian Patents and Development Limited Société Canadienne des Brevets et d'Exploitation Limitée (CA) 1984-03-28 EP disclosed
EP-0029009-B1 PREPARATION OF PIGMENTS CIBA-GEIGY AG (CH) 1983-12-21 EP disclosed
US-4341701-A Production of pigments CIBA-GEIGY CORPORATION (US) 1982-07-27 US disclosed
EP-0055218-A2 Manufacture of azoic compounds CIBA-GEIGY AG (CH) 1982-06-30 EP disclosed
EP-0012944-B1 COLOUR-FAST MONOAZO PIGMENT MIXTURES STABLE AGAINST RECRYSTALLISATION, PROCESS FOR THEIR PREPARATION AND THEIR USE HOECHST AKTIENGESELLSCHAFT (DE) 1982-06-23 EP disclosed
EP-0012944-A1 Colour-fast monoazo pigment mixtures stable against recrystallisation, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1980-07-09 EP disclosed
US-4169091-A Symmetrical and asymmetrical disazo compounds containing a bis-(nitro-aryloxy)alkane middle component HOECHST AKTIENGESELLSCHAFT (DE) 1979-09-25 US disclosed
US-3971741-A DISPERSION PIGMENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312402-A1 Novel Zirconium Compound, Catalyst and Its Use for Polyurethane Manufacture FTO, ALKBH3, KHK MEN1 4824/4885KMT2A 127/4885POLB 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.